Stewart Fisher - May 26, 2022 Form 4/A - Amendment Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Scientific Officer
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
May 26, 2022
Transactions value $
-$7,725
Form type
4/A - Amendment
Date filed
6/14/2022, 04:45 PM
Date Of Original Report
May 27, 2022
Previous filing
May 27, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability -$7.73K -1.1K -1.47% $7.01 74K May 26, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of performance restricted stock units and does not represent a sale by the Reporting Person.

Remarks:

This Form 4/A is being filed to disclose shares withheld to satisfy tax withholding obligations which were inadvertently omitted from the original Form 4 filing.